Key result
Fluoropolymer everolimus-eluting stents show thrombo-resistance in high inflammation but non-cardiac surgery outcomes remain unknown.
Why the study?
Fluoropolymer everolimus-eluting stents have inherent thrombo-resistant properties, but whether this improves outcomes in patients undergoing non-cardiac surgery was unknown.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Fluoropolymer everolimus eluting stents (EES) have been shown to have inherent thrombo-resistant properties including in high inflammatory conditions like COVID-19 induced cytokine storm. Whether this property results in improved outcomes in patients undergoing non-cardiac surgery (NCS), a state of heightened inflammation, is not known.
No takes yet. Share an insight, caveat, or question.
Bangalore et al. (2025) studied this question. Fluoropolymer everolimus-eluting stents demonstrate thrombo-resistant properties in high inflammatory conditions, but their effect on outcomes during non-cardiac surgery remains unknown.
Synapse has enriched 10 related papers. Consider them for comparative context: